Table I.
Characteristics of the Study Sample (N=65)
| Age, y | 69±11 |
| Female, No. (%) | 17 (26) |
| Body height, cm | 170±7.9 |
| Weight, kg | 74.5±12.6 |
| Body mass index, kg/m2 | 25.7±3.7 |
| Cardiovascular risk factors, No. (%) | |
| Hypertension | 52 (80) |
| Ever smokers | 48 (74) |
| Diabetes | 15 (23) |
| Dyslipidemia | 39 (60) |
| Comorbidities, No. (%) | |
| Coronary artery disease | 19 (29) |
| Cerebrovascular disease | 15 (23) |
| Renal insufficiency | 8 (12) |
| Medication, No. (%) | |
| Nitrates | 2 (3) |
| β‐Blockers | 35 (54) |
| Angiotensin‐converting enzyme inhibitors | 28 (43) |
| Angiotensin receptor blockers | 16 (25) |
| Calcium channel blockers | 19 (29) |
| Diuretics | 30 (46) |
| Lipid‐lowering medication | 54 (83) |
Values are expressed as mean±standard deviation for quantitative variables and numbers (percentages) for categorical variables.